Published February 22, 2025 | Version v1
Journal article Open

MANAGING THE EVOLUTION OF HEALTHCARE: INTEGRATING GENETIC ENGINEERING INTO MODERN MEDICINE

Authors/Creators

  • 1. Baku State University

Description

Genetic engineering is one of the newest directions of biotechnology, a modern technology based on the modification of genes and their certain properties, silencing some genes or replacing them with new ones. The ideas of giving new properties to living things or increasing their productivity were implemented in ancient times by traditional selection methods. However, discoveries in the field of molecular biology and genetics led to the emergence of a new field called genetic engineering.
In the 1990s, the characteristics of the human genome were completed (Human Genome Project), and genetic engineering was no longer aimed at plants and animals, but also at humans and began to play a new key role in the treatment of diseases. Currently, genetic engineering methods are used directly and indirectly in the treatment of widespread diseases such as cancer.
As early as 1972, the concept of gene therapy for human diseases was openly put forward by Theodore 
Friedman and Richard Roblin, who proposed the use of “good” deoxyribonucleic acid (DNA) to replace defective 
DNA as a treatment for hereditary diseases.
This article will discuss the methods of using genetic engineering in the therapeutic field, gene therapy and the technology of obtaining genetic engineering vaccines - DNA and mRNA. Also, some bioethical laws applied to this field at the global level will be discussed and the attitude towards genetic modification operations will be evaluated.

Files

Deutsche internationale Zeitschrift für zeitgenössische Wissenschaft №98 2025-6-11.pdf

Files (710.9 kB)

Additional details

References

  • 1. Babale, Y. K., & Atoi, E. N. (2021). Ethical concerns and risk perceptions associated with the application of genetic engineering. KIU Journal of social sciences, 7(3), 231-238. 2. Bellenger, J. P., Darnajoux, R., Zhang, X., & Kraepiel, A. M. L. (2020). Biological nitrogen fixation by alternative nitrogenases in terrestrial ecosystems: a review. Biogeochemistry, 149, 53-73. 3. Buedo, P., Bianchini, A., Klas, K., & Waligora, M. (2023). Bioethics of somatic gene therapy: what do we know so far?. Current Medical Research and Opinion, 39(10), 1355-1365. 4. Gupta, V., Sengupta, M., Prakash, J., Tripathy, B. C., Gupta, V., Sengupta, M., ... & Tripathy, B. C. (2017). Biosafety and bioethics. Basic and Applied Aspects of Biotechnology, 503-520. 5. Kose, S. B. E., SURa, Ü., Yirun, A., Balcı, A., Gümüşel, B. K., & Erkekoglu, P. (2020). CRISPRCas9 Teknolojisi, Güvenliliği ve Etik Açıdan Değerlendirilmesi. Literatür Eczacılık Bilimleri Dergisi, 9(1), 50-64. 6. Lee, J., Kumar, S. A., Jhan, Y. Y., & Bishop, C. J. (2018). Engineering DNA vaccines against infectious diseases. Acta Biomaterialia, 80, 31-47. 7. Lundstrom, K. (2023). Viral vectors in gene therapy: Where do we stand in 2023?. Viruses, 15(3), 698. 8. Mittal, M., Kumari, A., Paul, B., Varshney, A., Saini, A., Verma, C., & Mani, I. (2024). Challenges and Opportunities of Gene Therapy in Cancer. OBM Genetics, 8(1), 1-501. 9. Pfeifer, A., & Verma, I. M. (2001). Gene therapy: promises and problems. Annual review of genomics and human genetics, 2(1), 177-211. 10. Rubanyi, G. M. (2001). The future of human gene therapy. Molecular aspects of medicine, 22(3), 113-142. 11. SAMSUNLU, E. T. (2021). Gen Terapisinde CRISPR-Cas9. Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, 8(3), 574-580. 12. Sandler, R. (2020). The ethics of genetic engineering and gene drives in conservation. Conservation Biology, 34(2), 378-385. 13. SAREYYÜPOĞLU, B., & İZGÜR, M. (1999). DNA immunizasyonu. Etlik Veteriner Mikrobiyoloji Dergisi, 10(2), 73-85. 14. Silveira, M. M., Moreira, G. M. S. G., & Mendonça, M. (2021). DNA vaccines against COVID-19: Perspectives and challenges. Life sciences, 267, 118919. 15. Van Berkel, P. H., Welling, M. M., Geerts, M., van Veen, H. A., Ravensbergen, B., Salaheddine, M., ... & Nibbering, P. H. (2002). Large scale production of recombinant human lactoferrin in the milk of transgenic cows. Nature biotechnology, 20(5), 484-487. 16. Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2019). Three decades of messenger RNA vaccine development. Nano Today, 28, 100766. 17. Verma, I. M., & Weitzman, M. D. (2005). Gene therapy: twenty-first century medicine. Annu. Rev. Biochem., 74, 711-738. 18. Wang, Y., Zhang, Z., Luo, J., Han, X., Wei, Y., & Wei, X. (2021). mRNA vaccine: a potential therapeutic strategy. Molecular cancer, 20(1), 33. 19. Zepp, F. (2010). Principles of vaccine design—lessons from nature. Vaccine, 28, C14-C24. 20. 임현주. (2019). 넙치의 스쿠티카증 및 바이러스성 출혈성 패혈증 예방을 위한 DNA 백신 (Doctoral dissertation, 부경대학교)